Gujarat Themis Biosyn Limited Financial Ratios
GUJTHEM · Healthcare · Current price ₹372
P/E ratio
86.9x
P/B ratio
7.4x
ROE
16.2%
ROCE
14.5%
Debt / Equity
0.56
Dividend yield
0.2%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 86.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 7.4x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 16.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 14.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.56 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Gujarat Themis Biosyn Limited's latest numbers.
Gujarat Themis Biosyn Limited profitability
Gujarat Themis Biosyn Limited generates a return on equity of 16.2% and a return on capital employed of 14.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.56 and a P/E of 86.9x, Gujarat Themis Biosyn Limited is moderately leveraged. Our overall business-quality score for the company is 3.8 / 10.
Understand the ratios
More on Gujarat Themis Biosyn Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.